Related Experiment Video
Updated: Mar 1, 2026

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
Published on: March 30, 2017
Pediatric Aerosol Therapy
1Pulmonary Medicine Section, Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas and the Pediatric Aerosol Research Laboratory, Arkansas Children's Research Institute. Little Rock, Arkansas. berlinskiariel@uams.edu.
Insights
Optimizing inhaled medication delivery in children is crucial for treating lung diseases. Proper device and technique selection enhances drug deposition in the lungs for conditions like asthma.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Pharmacology
Background:
- Inhaled medications are essential for managing pediatric pulmonary conditions.
- Effective drug delivery to the lungs is critical for treatment success.
- Device and technique selection significantly impacts lung deposition.
Purpose of the Study:
- To review optimal inhaled medication delivery strategies in pediatric patients.
- To discuss device and technique selection for improved lung deposition.
- To examine delivery in specific pediatric clinical scenarios.
Main Methods:
- Literature review focusing on pediatric age groups (excluding neonates).
- Analysis of delivery techniques for acute pediatric asthma.
- Evaluation of aerosol delivery via tracheostomies and mechanical ventilation (noninvasive and invasive).
Main Results:
- Specific devices and techniques are more effective for certain pediatric conditions.
- Transnasal aerosol delivery requires specialized approaches.
- Delivery during mechanical ventilation necessitates careful technique to maximize lung deposition.
Conclusions:
- Tailoring device and delivery methods to the clinical situation improves inhaled therapy outcomes in children.
- Further research may refine delivery techniques for complex pediatric respiratory cases.
- Optimized delivery is key to maximizing therapeutic benefits of inhaled drugs in pediatric pulmonary disease.
Abstract:
Inhaled medications are the mainstay of therapy for many pediatric pulmonary diseases. Device and delivery technique selection is key to improving lung deposition of inhaled drugs. This paper will review the subject in relationship to several pediatric clinical situations: acute pediatric asthma, transnasal aerosol delivery, delivery through tracheostomies, and delivery during noninvasive and invasive mechanical ventilation. This review will focus on the pediatric age group and will not include neonates.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...

